Calcium and Vitamin D to Optimize Bone Mass in Boys with Risperidone-induced Hyperprolactinemia

Calcium and Vitamin D to Optimize Bone Mass in Boys with Risperidone-induced Hyperprolactinemia
Study Type: Interventional
Age/Gender Requirements: 5-17 years (male)
Sponsor: University of Iowa
Purpose: Over the course of a nine-month period, study participants will be given a placebo or calcium carbonate 625mg and vitamin D 200IU, orally, twice per day in order to assess the experimental combination’s affect on “trabecular bone mineral density in the ultradistal radius” and “total body bone mineral content.”
http://hcp.lv/gVVsGE